(Q40909020)

24 September 2017

1 reference

title

Current and future drug therapies for claudication (English)

1 reference

24 September 2017

1 reference

W R Hiatt

1

1 reference

24 September 2017

1 January 1997

1 reference

24 September 2017

1 reference

24 September 2017

2

1 reference

24 September 2017

257-262

1 reference

24 September 2017

3

1 reference

The prevalence of peripheral arterial disease in a defined population

24 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Arteriosclerosis Obliterans: Review of 520 Cases with Special Reference to Pathogenic and Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans, Louisiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Effects of colestipol-niacin therapy on human femoral atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

The peripheral vascular consequences of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Drug therapy: vasodilator drugs in peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

A dose-effect study of beraprost sodium in intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

Increase of walking capacity after acute aminophylline administration in intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X9700200316

10.1177/1358863X9700200316

21 January 2018

Identifiers

DOI

1 reference

release_n6ejfndlyrasjojwohbu57r23y

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n6ejfndlyrasjojwohbu57r23y

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9546977

1 reference

PubMed ID

9546977